Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
395,322,451
-
Total 13F shares
-
213,023,331
-
Share change
-
-7,200,999
-
Total reported value
-
$462,262,436
-
Put/Call ratio
-
70%
-
Price per share
-
$2.17
-
Number of holders
-
249
-
Value change
-
-$12,426,305
-
Number of buys
-
119
-
Number of sells
-
114
Institutional Holders of IOVANCE BIOTHERAPEUTICS, INC. - COMMON STOCK (IOVA) as of Q3 2025
As of 30 Sep 2025,
IOVANCE BIOTHERAPEUTICS, INC. - COMMON STOCK (IOVA) was held by
249 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
213,023,331 shares.
The largest 10 holders included
MHR FUND MANAGEMENT LLC, BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, Invenomic Capital Management LP, Long Focus Capital Management, LLC, Palo Alto Investors LP, GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, and BANK OF AMERICA CORP /DE/.
This page lists
249
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.